Every human life is precious and sacred and saving one is like saving the whole of humanity. (Al Quran 5:32/33)
By Tim Loh, January 27, 2021, 3:01 AM EST
- Collaboration will help boost European Union’s vaccine supply
- Companies pledge more than 125 million doses of mRNA shot
The French drugmaker will give BioNTech access to a production facility in Frankfurt, which will start to deliver doses this summer, Sanofi said in a statement Wednesday. The deal will produce more than 125 million doses of the messenger RNA vaccine for the European Union.
Sanofi’s own effort to develop a vaccine with another big pharma firm, GlaxoSmithKline Plc, stumbled in clinical tests, meaning it won’t be ready by summer as expected. The production agreement allows the region to make up for some of the loss, accelerating the complex process of packaging and distributing a vaccine that needs to be kept at ultra-cold temperatures.
Pfizer and BioNTech have been looking for ways to increase the supply of their immunization, from expanding existing plants to adding suppliers and contract manufacturers.